ZIEXTENZO 6 MG INJ SOL ISP 1X0,6ML
Rychlý přehled
| Dosage form | Solution injectable in a pre-filled syringe |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, zkontrolujte ale specializaci předepisujícího lékaře níže (tzv. nedelegovatelná preskripce). Maximální doplatek: 13 447,22 Kč. Maximální cena: 20 774,96 Kč. |
| Kdo může předepsat | clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecologyhematology and transfusion medicine, pediatric oncology and hematology |
| Složení | Pegfilgrastim (6 mg), ledová kyselina octová, sorbitol, polysorbát 20, solution hydroxidu sodného, voda pro injekci (0,6 ml). More information about the composition can be found in the SPC, section 6.1. |
| Dostupnost / výpadek | Výpadek The latest report from the manufacturer is from 9. 7. 2026. Výroba byla přerušena od 9. 7. 2026. The stated reason was: Výrobní důvody. Resumption of supply is expected 28. 8. 2026Výrobce jako potenciální náhradu uvádí léky s kóde… |
| Kód SÚKL | 0238245 |
What is the maximum co-payment for ZIEXTENZO?
If the insurance company contributes, the maximum co-payment is 13 447,22 Kč. The maximum pharmacy price is 20 774,96 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).
Does ZIEXTENZO have a counted co-payment set?
Yes, the medicine has a counted co-payment of 5 320,00 Kč. Learn more about the protective limit here.
How much does the insurance company pay for one dispensed reimbursed pack?
7 327,74 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe ZIEXTENZO?
- clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology
- hematology and transfusion medicine, pediatric oncology and hematology
What is the composition of ZIEXTENZO?
Pegfilgrastim (6 mg), ledová kyselina octová, sorbitol, polysorbát 20, solution hydroxidu sodného, voda pro injekci (0,6 ml). More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
Which medicines are similar to ZIEXTENZO?
The medicine belongs to ATC group L03AA13 – Pegfilgrastim. Medicines with the same active substance can be found here.
Who manufactures ZIEXTENZO?
SANDOZ GMBH, KUNDL (A)
Is the medicine in shortage?
The latest report from the manufacturer is from 9. 7. 2026. Production was interrupted as of 9. 7. 2026. The stated reason was: Výrobní důvody.
Resumption of supply is expected 28. 8. 2026
The manufacturer lists medicines with the following code as a potential substitute:
What is the unique code for ZIEXTENZO?
The medicine has code 0238245. Code details can be found here.
How many packs of ZIEXTENZO were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of ZIEXTENZO were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026